Clinical Trials Update: Jan. 19, 2006

Gastroesophageal Reflux Disease (GERD) Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Tinea Versicolor (Sunspot Fungus)

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

Gastroesophageal Reflux Disease (GERD)

Are you troubled by frequent episodes of heartburn, indigestion or sour stomach? Clinical Research Associates is conducting a series of research studies of an investigational medication for gastroesophageal reflux disease (GERD) symptoms. To qualify, you must be at least 18, have a history of frequent episodes of heartburn for six months or longer, and be willing to undergo screening procedures which may include endoscopy. Research site located in Nashville, Tenn.

More Information

Please see http://www.centerwatch.com/patient/studies/cat70.html.

-----

Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

This Japanese study will evaluate the efficacy of starting dose of AMG 531 for patients diagnosed with ITP according to diagnostic criteria proposed by Japan's Ministry of Health, Labor and Welfare. Males and females 20-70 years of age may be eligible. Research site located in Japan.

More Information

Please see http://www.centerwatch.com/patient/studies/cat666.html.

-----

Tinea Versicolor (Sunspot Fungus)

People with skin spots, skin discolorations, or discolored patches of skin are needed for a clinical research trial. Male or non-pregnant, non-lactating females 18 or older, with clinical signs and symptoms of tinea versicolor may be eligible. Study visits include a screening and two additional office visits over one month. Research site located in Anaheim, Calif.

More Information

Please see http://www.centerwatch.com/patient/studies/cat619.html.

-----

Copyright 2006 CenterWatch. All rights reserved.

Consumer News